drugset / Trial / NCT02266875
Nebulized Hypertonic Saline for Inpatient Use in COPD
RandomizedParallel-groupSingle-blindTreatment
Summary
A comparison of albuterol treatments using hypertonic saline (3%) versus standard saline (0.9%) in patients with admitted patients COPD in regard to Modified Borg Dyspnea scale scores after 4 treatments within 24 hours.
Timeline
- Start
- 2014-10
- Primary completion
- 2017-01-30
- Completion
- 2017-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 3 % | Other |